Isomorphic Labs’ $5B Series C is the largest venture round in European history
Isomorphic Labs, the London AI drug discovery company spun out of DeepMind in 2021, raised $5B in a Series C announced on 17 November 2026, co-led by Greenoaks and Sequoia. The round is 52% larger than Europe’s previous record, Mistral AI’s $3.3B Series D in September 2026.
Isomorphic has raised $7.7B from outside investors in three rounds since March 2025, and two of them are among Europe’s ten largest. The company has no drug in human trials yet; it plans its first clinical trials for the end of 2026. It has not disclosed a valuation, and Bloomberg reported talks at about $50B.
Isomorphic Labs’ $5B Series C is the largest venture round ever raised by a European company
Europe’s 10 largest venture rounds · 8 of the 10 were raised in 2025 or 2026
- 1London · Nov 2026$5B
- 2Mistral AIParis · Sep 2026$3.3B
- 3NorthvoltStockholm · Jun 2021$2.75B
- 4London · May 2026$2.1B
- 5London · Mar 2026$2B
- 6London · Jul 2025$2B
- 7Mistral AIParis · Sep 2025$1.87B
- 8HelsingMunich · Jul 2026$1.8B
- 9Stockholm · Sep 2023$1.65B
- 10Stockholm · Jun 2026$1.54B
A record that stood for five years
Northvolt’s $2.75B round in June 2021 was the largest venture round raised by a European company until September 2026, when Mistral AI raised $3.3B. Isomorphic’s round two months later is $1.7B larger again. Northvolt filed for bankruptcy in March 2025.
Northvolt’s $2.75B held Europe’s record for five years; it has been beaten twice since September
Largest venture round raised by a European company each year · dark bars set a new record
40% of European health funding
European health companies have raised $17.6B in venture funding in 2026. Isomorphic’s Series B and Series C, $7.1B together, are 40% of it, and 13% of the $56B raised by European AI companies.
Who invested
Alphabet has invested in every round, directly and through GV and CapitalG. Isomorphic does not publish its shareholdings; City AM reported in October 2026 that Alphabet was still the majority owner. Of the ten investors named in the Series C, the UK Sovereign AI Fund is the only one headquartered in Europe. MGX is based in Abu Dhabi and Temasek in Singapore.
Seven of the ten named investors in the Series C are American; one is European
Isomorphic Labs’ investors by round, coloured by where they are headquartered · stake sizes not disclosed
Where Europe’s largest rounds get their money
43 of Europe’s 50 largest venture rounds had at least one US investor. Splitting each round equally among its named investors, US investors supplied 48% of the money and European investors 29%. In rounds raised in 2025 and 2026 the US share was 53%.
US investors put up 48% of the money in Europe’s 50 largest venture rounds; European investors 29%
Share of round value by investor headquarters · each round split equally among its named investors
What this means
8 of Europe’s ten largest venture rounds were raised in 2025 or 2026, and most of the money in Europe’s largest rounds comes from investors outside Europe. The largest of them went to a company that has not yet started a clinical trial.
Research notes: method and sources
Rounds: Dealroom venture rounds for companies headquartered in Europe (Dealroom’s Europe region, which includes Türkiye), excluding mature companies and companies outside tech. The rankings use verified rounds only. Two companies are left out because they count as European only through a later move of their headquarters to Dublin: PDD Holdings ($3B in April 2018, then based in Shanghai) and Jazz Pharmaceuticals (2004, then based in Palo Alto). 2026 figures run to 18 November.
Investor regions: each investor’s headquarters as recorded by Dealroom. Stakes are not disclosed, so each round’s value is split equally among its named investors. Isomorphic’s round amounts are checked against the company’s releases; the Series C also had new investors the company did not name.
- Isomorphic Labs: Series C announcement (17 Nov 2026)
- Isomorphic Labs: Series B announcement (12 May 2026)
- tech.eu: Isomorphic Labs nets $600M in first external funding round (31 Mar 2025)
- TechCrunch: Isomorphic Labs raises $5B (17 Nov 2026)
- Dealroom news: Bloomberg on talks at about $50B (Nov 2026)
- City AM: funding talks and Alphabet majority ownership (8 Oct 2026)